chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt recieved a flu shot, Afluria, in the right arm and a pnuemonia shot, Pneumovax, in the left arm at the Kroger pharmacy around noon on Saturday, 10-4-08.  Pt called back at 5:30 pm that day to tell us that she was having a lot of pain and swelling in her left arm and that she could feel a golf ball size knot where the shot was given.  I checked the consent form and told the pt that she had recieved the pneumo shot in the left arm and that it sounded to me like she was having an allergic reaction.  I advised the pt to immediately seek treatment from a medical doctor at the instant care center or the hospital ER.  I gave the pt my cell phone number and told her to call me later and let me know how she was.  Pt was treated that night at the ER for an allergic reaction to the vaccine.
Patient reports received 2nd dose COVID Moderna vaccine around 11am 5/14/21. A few hours later, noticed red bumps (not itchy) on abdomen. Rash on abdomen, buttocks, and back mainly.   After 1st dose, only adverse effect was sore arm. No rash.
She got her vaccine, started feeling more and more as the day progressed that her arm was hurting and then as the day progressed she felt like her last 2 fingers in her left hand were tingling, and that extends up towards her forearm.  This morning they hurt extremely bad, she cannot open a container, and having ulnar nerve pain, cannot do anything as she cannot use the entire hand due to the pain and has weakness in that hand.  She is not having any other pain.  She has not taken anything for her symptoms.
Sore at injection sight for 3 days; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 20Jul2021 (Lot number: EW0217) at the age of 44 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Bicuspid aortic valve" (unspecified if ongoing); "Ascending aortic aneurysm" (unspecified if ongoing); "Mild AI" (unspecified if ongoing); "Known allergies: Tree nuts" (unspecified if ongoing); "Known allergies: Iodinated diagnostic agents" (unspecified if ongoing); "Known allergies: Gluten" (unspecified if ongoing). Concomitant medication(s) included: METOPROLOL; ATORVASTATIN. Past drug history included: Gentamicin, reaction(s): "Known allergies: Gentamicin"; Ciprofloxacin, reaction(s): "Known allergies: Ciprofloxacin". The following information was reported: VACCINATION SITE PAIN (non-serious) with onset Jul2021, outcome "recovered" (Jul2021), described as "Sore at injection sight for 3 days". Additional information: If other vaccine in four weeks: No. Other medications in two weeks: Metoprolol 25mg, Atorvastatin 10mg. If covid prior vaccination: No. If covid tested post vaccination: No   No follow-up attempts are possible. No further information is expected.
Patient describes having a very red face with associated hotness. Some relief after oral Benadryl but redness remains after three days. Patient has been using cold compresses. No other reported symptoms.
RECIEVED COVID VACCINE X 2 .HOSPITALIZED  WITH SOB,CHILLS FEVER . PLACED IN ICU ON HIGH FLOW O2
Headache as soon as waking up - after a few hours, chills and fatigue that had to go home from work and sleep all day.
Parent was contacted at 5:54 pm on 2/21/2022 and informed that the Hepatitis A vaccine was given 3 months early, inadvertently and that she would need another dose in 5/2022. On 2/21/2022 at 6:19 pm, the parent called physician to report fever of 102-103, confirmed by parent with ear, forehead and laser thermometers. She was listless but otherwise well. At 10:42 pm, she had an episode of decreased awareness and shakiness. She was talking within 2-3 minutes and was back to herself within several more minutes. The morning of 2/22/2022, parent reported to physician that she was acting like her normal self. On 2/23/2022, she was taken to an emergency department where it was reported to physician that she had had another spell the evening of 2/22/2022 with rigid body, head arching and eyes rolling backward. Exam was reported by physician as being normal on 2/23/2022.
2 Days after - low grade fever, malaise, sore throat; 3 days later tingling Right foot, 4th day tingling in left foot started. 1 week later - tingling in right hand then next day noted in left hand; also noted hands stiff and painful. Tingling/pain in Feet and Hands continue with increase pain in evening and from overuse.
pain in the upper arm where he got the shot after the first dose; This is a spontaneous report received from a contactable consumer. A contactable consumer reported that, a 59-year-old male consumer (patient) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: ER8732; Expiration Date: 01Apr2021), dose 1 via an unspecified route of administration, administered in right upper arm deltoid area on 01Apr2021 at 10:30 (at the age of 59-year-old) as a DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included neck surgery from an unknown date and unknown if ongoing he has had surgery on his neck, but this was before the shots and related to his disability. It was done on C5, C6, C7, he had a discectomy done in either 2017-2018. The patient's concomitant medications were not reported. History of all previous immunization with the Pfizer vaccine considered as suspect (or patient age at first and subsequent immunizations if dates of birth or immunizations are not available) were none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Prior Vaccinations (within 4 weeks) and events following prior vaccinations were none. Patient's Medical History (including any illness at time of vaccination) were none. The patient experienced pain in the upper arm where he got the shot after the first dose on an unspecified date in Apr2021. It was reported that, he received 2 doses of the COVID Vaccine in Apr2021 and is still having pain in the upper arm with numbness and tingling. The patient confirmed it is the Pfizer COVID Vaccine. he was disable but use to work as a medical tech. Reporter wanted to know what he should do, where does he go from here. No treatments were reported for the event. Events did not require a visit to the Emergency Room or Physician Office (his next step would be to call his primary care). Relevant Tests done were none. Reporter seriousness for the event was Unspecified. Outcome of the event was not recovered.  Follow-up actions are needed. Further information has been requested.
2 days p/vax pt devel a fine red rash on rt arm from upper arm to elbow & in elbow crease & a rash on both thighs in crease of knees;rash was red & prickly;seen by MD;itching;blotch @ inj site;
Expired vaccine (Rotateq) was accidentally administered. Expiration date was not verified until after the vaccine was administered. Vaccine had expired 3 months prior to administration date. No adverse symptoms were reported. Patient tolerated all vaccines well.
Administered Fluarix in left arm. Took needle out and arm began swelling in egg shape, hard mass. Applied ice pack, gave Benadryl 50 mg capsule. Swelling was the only sign of adverse reaction.
This spontaneous report was received from a physician assistant via a company representative and refers to a 21 years old female patient with a medical history of asplenia. In approximately February 2005, at the patient's age of 21 years, the patient was administered the first dose of PNEUMOVAX 23. In February 2015, at the patient's age of 31 years, the patient was vaccinated with the second dose of PNEUMOVAX 23 (route of administration, lot number and expiry date were not reported). On an unknown date in 2015, after the second vaccination, the patient experienced a really bad cough, a really high fever, chills and body aches. The patient was unable to speak due to the severity of coughing and unable to move the arms due to the severity of the body aches. The patient went to the emergency room. It was not specified whether the patient was admitted. The patient's illness lasted 2 weeks until resolving on an unspecified date, in approximately 2015. The relatedness between the vaccination with PNEUMOVAX 23 and the adverse events was not reported. Additional information has been requested.
No additional AEs or PQC reported; Caller reported vaccine administered after temperature excursions; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 29-JUL-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) injection, 0.5 milliliter, lot #W038809 rHA , expiration date: 04-JUN-2024, administered intramuscularly for prophylaxis (strength was not provided).  The improperly stored dose of the suspect vaccine experienced a temperature excursion of 18.3 degree fahrenheit for 1 hour and 5 minutes; no previous temperature excursions were reported.  No adverse symptoms were reported.
19APR91 pt felt had flu;pt devel neuropathy, pneumonia, sinusitis, hepatitis A, B & C;lab eval revealed anti-HBs positive;anti-HBc positive;HBsAg positive (prev neg SEP90);anti-HBsA positive;anti-HVC positive & liver enzymes abn;
BP147/83, patient reported tingling to R arm. Patient was administered 25mg of Benadryl Po. Complained of palpitations, probably related to anxiety. Ice pack was applied to back of the neck. Patient was discharged home.
CHILLS; JOINT PAIN; SENSITIVITY AT THE INJECTION SITE; MUSCLE ACHES; HEADACHE; FEVER UP TO 101 FAHRENHEIT; This spontaneous report received from a patient concerned a 44 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included pernicious anemia, non smoker, and ketosis, and other pre-existing medical conditions included the patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 10:00 for prophylactic vaccination. Concomitant medications included cyanocobalamin for pernicious anemia. On 08-APR-2021, the subject experienced chills. On 08-APR-2021, the subject experienced joint pain. On 08-APR-2021, the subject experienced sensitivity at the injection site. On 08-APR-2021, the subject experienced muscle aches. On 08-APR-2021, the subject experienced headache. On 08-APR-2021, the subject experienced fever up to 101 fahrenheit .Laboratory data included: Body temperature (NR: not provided) 98 F, 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, joint pain, muscle aches, headache, and fever up to 101 fahrenheit ,on 10-APR-2021, and had not recovered from sensitivity at the injection site. This report was non-serious.
Information has been received from a female consumer concerning herself who in 2008 was vaccinated with the first dose of GARDASIL (lot # not reported). It was reported that the patient developed tissue inflammation in the arm that she received GARDASIL. She also experienced the same symptoms and developed warts on her arm and hand within 48 hours of receiving her third dose of HPV. Unspecified medical attention was sought. At the time of this report, the patient's outcome was unknown. Additional information has been requested.
Patient's home healthcare worker tested positive for COVID19 and Filomena had some mild symptoms, so was tested 2/4/21. She had dry cough and tiredness. She received antibody treatment 2/5/21 outpatient. After infusion she had rash/ hives.
swollen lymph node and painful to touch; hives; This is a spontaneous report from a non-contactable consumer (patient) via a sales representative. A female patient of an unspecified age received second dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE ; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19  VACCINE; lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization, after which patient experienced some fatigue and headache for 24 hours. Patient had a swollen lymph node on side she received second shot. She was 6 days out and the swelling was down however it was still painful to touch. She also had hives 48 hours after 2nd dose that self-resolved on an unspecified date. She does take an immunosuppressant agent. The outcome of the event swollen lymph node and painful to touch was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021372009 same patient, different event/dose
Case number PHEH2015US020295, is an initial spontaneous report received from a nurse on 08 Oct 2015. This report refers to 54 year old female patient. Historical condition and concomitant medication were not provided. The patient was vaccinated with FLUVIRIN (batch number: 1515701) intramuscularly at a dose of 0.5 ml on 07 Oct 2015. It was reported that before administration the vaccine was stored out of temperature range at 47 degree Fahrenheit. No adverse event was reported following this maladministration.
had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long; had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long) and PRODUCT STORAGE ERROR (had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In October 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In October 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long) and PRODUCT STORAGE ERROR (had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long). In October 2021, EXPIRED PRODUCT ADMINISTERED (had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long) and PRODUCT STORAGE ERROR (had the 2nd jab of moderna; About 10 days later the hospital called and said the vaccine wasn't expired but had been in the fridge 7 days too long) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-428398 (Patient Link).
Patient reported severe headache beginning 1 hour after vaccine administration.  Patient took normal dose of topiramate that evening for migraine.  Patient woke up in the am with bilateral swollen wrists, hives with skin peeling, and itching on arms.  Patient was instructed to go immediately to urgent care center for treatment.
Uncontrollable shivering for 3 hours, headache, numbness and tingling in hands and feet, swelling and redness at injection site, swollen armpit, chest pain, extreme tiredness and slept for 22 hours, weakness.
This report was received from Abbott concerning a 16 year old female patient who on an unspecified date was vaccinated with a dose of GARDASIL. Shortly after the vaccination the patient developed uterine fibroids. It was unknown of the patient had sought medical attention. The status of the patient was unknown. This was originally reported by a consumer. No further information is available.
My arm hurt severely and the muscles in my arm would not contract to allow for motion until 11:00am on 1/8/21, but the pain was so severe that I could not sleep.  I have also had severe chills, nausea, vomited twice, generalized weakness and shakiness.  It is currently 12:10pm on 1/8/21 and these symptoms continue.  Two of my other co-workers were at this same facility at the same time on 1/7 and have had very similar symptoms as well as severe headache which prevented them to work today.  We are all physical therapists, healthy young individuals, no co-comorbidities and were very surprised by these negative reactions and concerned.
Pt was given 3rd vaccine dose - Mother filled out consent form and reported no allergies, sickness, or previous hx of adverse events after vaccines. Pt was administered dose and walked out to waiting area for the required 15 mins of observance. 5-7 mins later she felt dizzy and fainted. She was alert and conscience. Pt had no injuries but a headache. Pt's legs were elevated and was given water, juice, and snack because parent said she wasnt able to eat anything today. pt was also given alcohol swab in case. After 30+min of observance with parents, pt felt a lot better and parents did not want any ambulatory assistance. Parents felt pt was okay to go home and made sure to continue to observe.
Sudden onset of new/worsened bilateral high-frequency tinnitus. Tinnitus was unresolved as of several days into reaction; no specific treatments have been recommended.
As I left my father's manufacturing facility where I received the shot, I felt a little bit of a sore throat, but I thought I was just being paranoid. The next day, my sore throat continued (I am prone to sore throats), and I was fatigued, had some body aches, and had a pounding headache. I took a 30-minute nap throughout the day to relieve some fatigue (which is not something I normally do), and about 26 hours after the shot I took a pain killer (Sorry, I can't remember which kind) to attempt to alleviate the headache, but it didn't help much. The next day, I was totally fine.   This is all a very small price to pay for some protection from COVID-19. I just wanted to share the information in case it is useful to you.
Patient acquired hives, diarrhea, nausea, and vomiting about 10 to 12 hours after the injection. He took Benadryl for the hives with relief. He is still having diarrhea today.
This case was reported by a nurse via sales rep and described the occurrence of injection site redness in an adult female patient who received FLUARIX (batch number D3AF5, expiry date 9th June 2016). On 21st September 2015, the patient received FLUARIX .5 ml. On an unknown date, less than a week after receiving FLUARIX, the patient experienced injection site redness, injection site induration, injection site tenderness, generalized itching, injection site swelling and fever. On an unknown date, the outcome of the injection site redness, injection site induration, injection site tenderness, generalized itching, injection site swelling and fever were unknown. It was unknown if the reporter considered the injection site redness, injection site induration, injection site tenderness, generalized itching, injection site swelling and fever to be related to FLUARIX. Additional details were received as follows: Patient's age range went from around 25-55 years of age. In September 2015, less than a week after receiving FLUARIX, the patient experienced injection site redness, injection site induration, injection site tenderness, generalized itching, injection site swelling and fever. On 25th September 1015, the adverse events were noted. The date of birth and information on adverse events experienced by individual patients were unknown. Reporter just explained that the most common adverse event experienced was induration at the injection site. Also the patient experienced redness, swelling and tenderness at the injection site. Less commonly reported event was itching throughout the body. The least common reported event was fever. This case was one of the 9 cases reported by same reporter.
My singing voice was ruined.  All of my life, I have been able to sing about 2.5 octaves with a smooth clear strong voice.  Starting at roughly ten days after the first vaccination, I was barely able to sing one octave.  In particular, as I sang from low notes to high notes, the sound became increasingly scratchy until it turned into a horrible screech. As time passed, my voice partially recovered.  I can now sing almost 2 octaves, though most of the notes are scratchy.  It is unclear whether my voice will fully recover. My speaking voice was also slightly affected.  It became scratchier.
Adolescent patient received an adult dose; Adolescent patient received an adult dose; This case was reported by a other health professional via call center representative and described the occurrence of overdose in a 19-year-old female patient who received HBV (Engerix B adult) (batch number 9AX5P, expiry date 23rd November 2023) for prophylaxis.   On 29th January 2022, the patient received Engerix B adult. On 29th January 2022, unknown after receiving Engerix B adult, the patient experienced overdose and adult product administered to child. On an unknown date, the outcome of the overdose and adult product administered to child were unknown.  Additional details were provided as follows: The case was reported by the Medical assistant. The reporter stated that, an adolescent patient received an adult dose of Engerix-B, which led to overdose and adult product administered to child. The reporter consented to follow up.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 29Nov2021 at 12:00 as dose number unknown, single (Batch/Lot number: unknown) at the age of 61 years, in left arm for covid-19 immunisation; covid-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 13May2022 at 17:30 as dose number unknown, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Plantains" (unspecified if ongoing), notes: known allergies: Plantains. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "recovering" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Negative, notes: I had a rebound of covid 3 days after completing the meds and testing negative; Positive, notes: Symptoms started again I tested positive e again. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Clinical information: The patient did not receive any other medication in 2 weeks. Anti-viral details: Product-COVID 19 Treatment, Brand-Paxlovid, Treatment start date on 01Jun2022 and treatment stop date on 06Jun2022.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.